We are thrilled to share that our startup, Early is Good, was recently spotlighted on Startup Targets. Driven by Dr. Thakshila Liyanage’s personal commitment to early cancer detection, following the loss of her grandmother to the disease, our mission is to diagnose cancer at Stage 0. With the belief that ‘Early is Good’, we’re innovating a sensitive bladder cancer diagnostic test called BCDx. This groundbreaking test identifies biomarkers in urine, promising a more comfortable and efficient diagnostic process compared to current invasive methods.

To read the full story of our journey, Dr. Liyanage’s motivations, and the future of Early is Good, head over to Inside INdiana Business‘ feature article.